MD PhdRabin Medical Center, Ophthalmology Department and Laboratory of Eye Research Felsenstein Medical Research Center, Petah-Tikva, IsraelPetah-Tikva, Tel Aviv, Israel
OC 49.1 - 3K3A-Activated Protein C treatment exerts anti-inflammatory and blood barrier stabilizing effects in the retina, and inhibits choroidal neovascularization
Monday, June 26, 202314:45 – 15:00 ET
